nodes	percent_of_prediction	percent_of_DWPC	metapath
Valaciclovir—SLC22A8—nephron—kidney cancer	0.0235	0.132	CbGeAlD
Valaciclovir—SLC22A8—urine—kidney cancer	0.0189	0.106	CbGeAlD
Valaciclovir—SLC10A2—nephron tubule—kidney cancer	0.0182	0.102	CbGeAlD
Valaciclovir—SLC10A2—renal system—kidney cancer	0.0166	0.0926	CbGeAlD
Valaciclovir—SLC10A2—kidney—kidney cancer	0.016	0.0895	CbGeAlD
Valaciclovir—SLC10A2—cortex of kidney—kidney cancer	0.0156	0.0872	CbGeAlD
Valaciclovir—SLC22A6—nephron tubule—kidney cancer	0.00848	0.0475	CbGeAlD
Valaciclovir—SLC22A6—cortex of kidney—kidney cancer	0.00726	0.0406	CbGeAlD
Valaciclovir—SLC15A1—nephron tubule—kidney cancer	0.00706	0.0395	CbGeAlD
Valaciclovir—SLC15A1—renal system—kidney cancer	0.00642	0.0359	CbGeAlD
Valaciclovir—SLC15A1—kidney—kidney cancer	0.0062	0.0347	CbGeAlD
Valaciclovir—SLC22A8—nephron tubule—kidney cancer	0.00508	0.0284	CbGeAlD
Valaciclovir—SLC22A8—renal system—kidney cancer	0.00462	0.0258	CbGeAlD
Valaciclovir—SLC22A8—kidney—kidney cancer	0.00446	0.025	CbGeAlD
Valaciclovir—SLC15A2—nephron tubule—kidney cancer	0.00441	0.0247	CbGeAlD
Valaciclovir—SLC22A8—cortex of kidney—kidney cancer	0.00435	0.0243	CbGeAlD
Valaciclovir—SLC15A2—renal system—kidney cancer	0.00401	0.0224	CbGeAlD
Valaciclovir—SLC15A2—kidney—kidney cancer	0.00388	0.0217	CbGeAlD
Valaciclovir—SLC15A2—cortex of kidney—kidney cancer	0.00378	0.0211	CbGeAlD
Valaciclovir—SLC10A2—Orphan transporters—ANXA2—kidney cancer	0.00134	0.0431	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.0013	0.0416	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	0.00123	0.0392	CbGpPWpGaD
Valaciclovir—SLC6A14—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.00118	0.0379	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—SLC5A3—kidney cancer	0.000938	0.03	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—kidney cancer	0.000903	0.0289	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—KEAP1—kidney cancer	0.00082	0.0262	CbGpPWpGaD
Valaciclovir—SLC6A14—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.000697	0.0223	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	0.000651	0.0208	CbGpPWpGaD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000591	0.0189	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000572	0.0183	CbGpPWpGaD
Valaciclovir—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.00056	0.0179	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000523	0.0167	CbGpPWpGaD
Valaciclovir—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.00052	0.0167	CbGpPWpGaD
Valaciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000508	0.0163	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—SLC5A5—kidney cancer	0.000495	0.0158	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—SLC2A1—kidney cancer	0.000478	0.0153	CbGpPWpGaD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	0.000468	0.015	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000456	0.0146	CbGpPWpGaD
Valaciclovir—SLC6A14—NRF2 pathway—EGR1—kidney cancer	0.000443	0.0142	CbGpPWpGaD
Valaciclovir—Dermatitis—Everolimus—kidney cancer	0.000425	0.000538	CcSEcCtD
Valaciclovir—Headache—Vinblastine—kidney cancer	0.000425	0.000537	CcSEcCtD
Valaciclovir—Angioedema—Paclitaxel—kidney cancer	0.000424	0.000537	CcSEcCtD
Valaciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000424	0.0136	CbGpPWpGaD
Valaciclovir—Headache—Everolimus—kidney cancer	0.000423	0.000535	CcSEcCtD
Valaciclovir—Abdominal pain—Dactinomycin—kidney cancer	0.000422	0.000534	CcSEcCtD
Valaciclovir—Body temperature increased—Dactinomycin—kidney cancer	0.000422	0.000534	CcSEcCtD
Valaciclovir—Asthenia—Sorafenib—kidney cancer	0.00042	0.000532	CcSEcCtD
Valaciclovir—Leukopenia—Paclitaxel—kidney cancer	0.000415	0.000526	CcSEcCtD
Valaciclovir—Hypersensitivity—Sunitinib—kidney cancer	0.000415	0.000526	CcSEcCtD
Valaciclovir—Decreased appetite—Vincristine—kidney cancer	0.000415	0.000525	CcSEcCtD
Valaciclovir—Pruritus—Sorafenib—kidney cancer	0.000415	0.000525	CcSEcCtD
Valaciclovir—Vomiting—Erlotinib—kidney cancer	0.000414	0.000524	CcSEcCtD
Valaciclovir—Erythema multiforme—Capecitabine—kidney cancer	0.000414	0.000524	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000412	0.000522	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Vincristine—kidney cancer	0.000412	0.000521	CcSEcCtD
Valaciclovir—Fatigue—Vincristine—kidney cancer	0.000411	0.000521	CcSEcCtD
Valaciclovir—Rash—Erlotinib—kidney cancer	0.000411	0.00052	CcSEcCtD
Valaciclovir—Dermatitis—Erlotinib—kidney cancer	0.00041	0.000519	CcSEcCtD
Valaciclovir—Insomnia—Gemcitabine—kidney cancer	0.000409	0.000518	CcSEcCtD
Valaciclovir—Headache—Erlotinib—kidney cancer	0.000408	0.000517	CcSEcCtD
Valaciclovir—Constipation—Vincristine—kidney cancer	0.000408	0.000516	CcSEcCtD
Valaciclovir—Pain—Vincristine—kidney cancer	0.000408	0.000516	CcSEcCtD
Valaciclovir—Osteoarthritis—Doxorubicin—kidney cancer	0.000408	0.000516	CcSEcCtD
Valaciclovir—Paraesthesia—Gemcitabine—kidney cancer	0.000406	0.000514	CcSEcCtD
Valaciclovir—Cough—Paclitaxel—kidney cancer	0.000405	0.000513	CcSEcCtD
Valaciclovir—Asthenia—Sunitinib—kidney cancer	0.000405	0.000512	CcSEcCtD
Valaciclovir—Dyspnoea—Gemcitabine—kidney cancer	0.000403	0.000511	CcSEcCtD
Valaciclovir—Nausea—Vinblastine—kidney cancer	0.000403	0.00051	CcSEcCtD
Valaciclovir—Somnolence—Gemcitabine—kidney cancer	0.000402	0.000509	CcSEcCtD
Valaciclovir—Convulsion—Paclitaxel—kidney cancer	0.000402	0.000509	CcSEcCtD
Valaciclovir—Migraine—Doxorubicin—kidney cancer	0.000401	0.000508	CcSEcCtD
Valaciclovir—Nausea—Everolimus—kidney cancer	0.000401	0.000508	CcSEcCtD
Valaciclovir—Diarrhoea—Sorafenib—kidney cancer	0.000401	0.000508	CcSEcCtD
Valaciclovir—Hypertension—Paclitaxel—kidney cancer	0.000401	0.000507	CcSEcCtD
Valaciclovir—Pruritus—Sunitinib—kidney cancer	0.000399	0.000505	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GSTP1—kidney cancer	0.000398	0.0128	CbGpPWpGaD
Valaciclovir—Immune system disorder—Capecitabine—kidney cancer	0.000395	0.0005	CcSEcCtD
Valaciclovir—Myalgia—Paclitaxel—kidney cancer	0.000395	0.0005	CcSEcCtD
Valaciclovir—Chest pain—Paclitaxel—kidney cancer	0.000395	0.0005	CcSEcCtD
Valaciclovir—Arthralgia—Paclitaxel—kidney cancer	0.000395	0.0005	CcSEcCtD
Valaciclovir—Mediastinal disorder—Capecitabine—kidney cancer	0.000394	0.000499	CcSEcCtD
Valaciclovir—Face oedema—Doxorubicin—kidney cancer	0.000394	0.000498	CcSEcCtD
Valaciclovir—Decreased appetite—Gemcitabine—kidney cancer	0.000393	0.000498	CcSEcCtD
Valaciclovir—Hypersensitivity—Dactinomycin—kidney cancer	0.000393	0.000498	CcSEcCtD
Valaciclovir—Chills—Capecitabine—kidney cancer	0.000393	0.000497	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000392	0.000497	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000391	0.000494	CcSEcCtD
Valaciclovir—Fatigue—Gemcitabine—kidney cancer	0.00039	0.000494	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Vincristine—kidney cancer	0.00039	0.000494	CcSEcCtD
Valaciclovir—Dizziness—Sorafenib—kidney cancer	0.000388	0.000491	CcSEcCtD
Valaciclovir—Pain—Gemcitabine—kidney cancer	0.000387	0.00049	CcSEcCtD
Valaciclovir—Constipation—Gemcitabine—kidney cancer	0.000387	0.00049	CcSEcCtD
Valaciclovir—Nausea—Erlotinib—kidney cancer	0.000387	0.00049	CcSEcCtD
Valaciclovir—Alopecia—Capecitabine—kidney cancer	0.000387	0.000489	CcSEcCtD
Valaciclovir—Dry mouth—Paclitaxel—kidney cancer	0.000386	0.000489	CcSEcCtD
Valaciclovir—Diarrhoea—Sunitinib—kidney cancer	0.000386	0.000488	CcSEcCtD
Valaciclovir—Ataxia—Doxorubicin—kidney cancer	0.000383	0.000485	CcSEcCtD
Valaciclovir—Asthenia—Dactinomycin—kidney cancer	0.000383	0.000485	CcSEcCtD
Valaciclovir—Confusional state—Paclitaxel—kidney cancer	0.000382	0.000483	CcSEcCtD
Valaciclovir—Blood creatinine increased—Doxorubicin—kidney cancer	0.000382	0.000483	CcSEcCtD
Valaciclovir—Dehydration—Doxorubicin—kidney cancer	0.000379	0.00048	CcSEcCtD
Valaciclovir—Anaphylactic shock—Paclitaxel—kidney cancer	0.000379	0.00048	CcSEcCtD
Valaciclovir—Oedema—Paclitaxel—kidney cancer	0.000379	0.00048	CcSEcCtD
Valaciclovir—Abdominal pain—Vincristine—kidney cancer	0.000377	0.000477	CcSEcCtD
Valaciclovir—Body temperature increased—Vincristine—kidney cancer	0.000377	0.000477	CcSEcCtD
Valaciclovir—Liver function test abnormal—Doxorubicin—kidney cancer	0.000376	0.000476	CcSEcCtD
Valaciclovir—Infection—Paclitaxel—kidney cancer	0.000376	0.000476	CcSEcCtD
Valaciclovir—Flatulence—Capecitabine—kidney cancer	0.000375	0.000475	CcSEcCtD
Valaciclovir—Dizziness—Sunitinib—kidney cancer	0.000373	0.000472	CcSEcCtD
Valaciclovir—Feeling abnormal—Gemcitabine—kidney cancer	0.000373	0.000472	CcSEcCtD
Valaciclovir—Vomiting—Sorafenib—kidney cancer	0.000373	0.000472	CcSEcCtD
Valaciclovir—Nervous system disorder—Paclitaxel—kidney cancer	0.000371	0.00047	CcSEcCtD
Valaciclovir—Thrombocytopenia—Paclitaxel—kidney cancer	0.000371	0.000469	CcSEcCtD
Valaciclovir—Tachycardia—Paclitaxel—kidney cancer	0.00037	0.000468	CcSEcCtD
Valaciclovir—Rash—Sorafenib—kidney cancer	0.000369	0.000468	CcSEcCtD
Valaciclovir—Dermatitis—Sorafenib—kidney cancer	0.000369	0.000467	CcSEcCtD
Valaciclovir—Back pain—Capecitabine—kidney cancer	0.000368	0.000466	CcSEcCtD
Valaciclovir—Skin disorder—Paclitaxel—kidney cancer	0.000368	0.000466	CcSEcCtD
Valaciclovir—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000367	0.000465	CcSEcCtD
Valaciclovir—Headache—Sorafenib—kidney cancer	0.000367	0.000465	CcSEcCtD
Valaciclovir—SLC6A14—NRF2 pathway—GSTM1—kidney cancer	0.000366	0.0117	CbGpPWpGaD
Valaciclovir—Diarrhoea—Dactinomycin—kidney cancer	0.000365	0.000462	CcSEcCtD
Valaciclovir—Nasopharyngitis—Doxorubicin—kidney cancer	0.000365	0.000462	CcSEcCtD
Valaciclovir—Anorexia—Paclitaxel—kidney cancer	0.000361	0.000457	CcSEcCtD
Valaciclovir—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00036	0.000455	CcSEcCtD
Valaciclovir—Vomiting—Sunitinib—kidney cancer	0.000359	0.000454	CcSEcCtD
Valaciclovir—SLC6A14—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	0.000358	0.0115	CbGpPWpGaD
Valaciclovir—Body temperature increased—Gemcitabine—kidney cancer	0.000358	0.000453	CcSEcCtD
Valaciclovir—Tremor—Capecitabine—kidney cancer	0.000357	0.000452	CcSEcCtD
Valaciclovir—Rash—Sunitinib—kidney cancer	0.000356	0.00045	CcSEcCtD
Valaciclovir—Dermatitis—Sunitinib—kidney cancer	0.000355	0.00045	CcSEcCtD
Valaciclovir—Headache—Sunitinib—kidney cancer	0.000353	0.000447	CcSEcCtD
Valaciclovir—Influenza—Doxorubicin—kidney cancer	0.000352	0.000446	CcSEcCtD
Valaciclovir—Anaemia—Capecitabine—kidney cancer	0.000352	0.000446	CcSEcCtD
Valaciclovir—Hypersensitivity—Vincristine—kidney cancer	0.000351	0.000445	CcSEcCtD
Valaciclovir—Nausea—Sorafenib—kidney cancer	0.000348	0.000441	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000345	0.000437	CcSEcCtD
Valaciclovir—Insomnia—Paclitaxel—kidney cancer	0.000343	0.000434	CcSEcCtD
Valaciclovir—Asthenia—Vincristine—kidney cancer	0.000342	0.000433	CcSEcCtD
Valaciclovir—Leukopenia—Capecitabine—kidney cancer	0.000341	0.000432	CcSEcCtD
Valaciclovir—Paraesthesia—Paclitaxel—kidney cancer	0.00034	0.000431	CcSEcCtD
Valaciclovir—Vomiting—Dactinomycin—kidney cancer	0.000339	0.00043	CcSEcCtD
Valaciclovir—Bronchitis—Doxorubicin—kidney cancer	0.000339	0.000429	CcSEcCtD
Valaciclovir—Dyspnoea—Paclitaxel—kidney cancer	0.000338	0.000428	CcSEcCtD
Valaciclovir—Somnolence—Paclitaxel—kidney cancer	0.000337	0.000426	CcSEcCtD
Valaciclovir—Rash—Dactinomycin—kidney cancer	0.000337	0.000426	CcSEcCtD
Valaciclovir—Nausea—Sunitinib—kidney cancer	0.000335	0.000424	CcSEcCtD
Valaciclovir—Dyspepsia—Paclitaxel—kidney cancer	0.000333	0.000422	CcSEcCtD
Valaciclovir—Cough—Capecitabine—kidney cancer	0.000332	0.000421	CcSEcCtD
Valaciclovir—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.00033	0.0106	CbGpPWpGaD
Valaciclovir—Decreased appetite—Paclitaxel—kidney cancer	0.000329	0.000417	CcSEcCtD
Valaciclovir—Hypertension—Capecitabine—kidney cancer	0.000329	0.000416	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000328	0.0105	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000328	0.0105	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000328	0.0105	CbGpPWpGaD
Valaciclovir—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000328	0.000415	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000327	0.000414	CcSEcCtD
Valaciclovir—Fatigue—Paclitaxel—kidney cancer	0.000327	0.000413	CcSEcCtD
Valaciclovir—Diarrhoea—Vincristine—kidney cancer	0.000326	0.000413	CcSEcCtD
Valaciclovir—Asthenia—Gemcitabine—kidney cancer	0.000325	0.000411	CcSEcCtD
Valaciclovir—Myalgia—Capecitabine—kidney cancer	0.000324	0.00041	CcSEcCtD
Valaciclovir—Chest pain—Capecitabine—kidney cancer	0.000324	0.00041	CcSEcCtD
Valaciclovir—Arthralgia—Capecitabine—kidney cancer	0.000324	0.00041	CcSEcCtD
Valaciclovir—Constipation—Paclitaxel—kidney cancer	0.000324	0.00041	CcSEcCtD
Valaciclovir—Pain—Paclitaxel—kidney cancer	0.000324	0.00041	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000322	0.000408	CcSEcCtD
Valaciclovir—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000322	0.000407	CcSEcCtD
Valaciclovir—Pruritus—Gemcitabine—kidney cancer	0.00032	0.000405	CcSEcCtD
Valaciclovir—Dry mouth—Capecitabine—kidney cancer	0.000317	0.000401	CcSEcCtD
Valaciclovir—Nausea—Dactinomycin—kidney cancer	0.000317	0.000401	CcSEcCtD
Valaciclovir—Dizziness—Vincristine—kidney cancer	0.000315	0.000399	CcSEcCtD
Valaciclovir—Confusional state—Capecitabine—kidney cancer	0.000313	0.000397	CcSEcCtD
Valaciclovir—Feeling abnormal—Paclitaxel—kidney cancer	0.000312	0.000395	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000312	0.00998	CbGpPWpGaD
Valaciclovir—Oedema—Capecitabine—kidney cancer	0.000311	0.000394	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00031	0.000392	CcSEcCtD
Valaciclovir—Diarrhoea—Gemcitabine—kidney cancer	0.00031	0.000392	CcSEcCtD
Valaciclovir—Renal failure—Doxorubicin—kidney cancer	0.000309	0.000391	CcSEcCtD
Valaciclovir—Infection—Capecitabine—kidney cancer	0.000309	0.000391	CcSEcCtD
Valaciclovir—Stomatitis—Doxorubicin—kidney cancer	0.000306	0.000388	CcSEcCtD
Valaciclovir—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.000306	0.0098	CbGpPWpGaD
Valaciclovir—Urinary tract infection—Doxorubicin—kidney cancer	0.000305	0.000387	CcSEcCtD
Valaciclovir—Nervous system disorder—Capecitabine—kidney cancer	0.000305	0.000386	CcSEcCtD
Valaciclovir—Thrombocytopenia—Capecitabine—kidney cancer	0.000304	0.000385	CcSEcCtD
Valaciclovir—Tachycardia—Capecitabine—kidney cancer	0.000303	0.000384	CcSEcCtD
Valaciclovir—Vomiting—Vincristine—kidney cancer	0.000303	0.000384	CcSEcCtD
Valaciclovir—Skin disorder—Capecitabine—kidney cancer	0.000302	0.000382	CcSEcCtD
Valaciclovir—SLC6A14—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000301	0.00964	CbGpPWpGaD
Valaciclovir—Urticaria—Paclitaxel—kidney cancer	0.000301	0.000381	CcSEcCtD
Valaciclovir—Rash—Vincristine—kidney cancer	0.000301	0.000381	CcSEcCtD
Valaciclovir—Dermatitis—Vincristine—kidney cancer	0.0003	0.00038	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.0003	0.00962	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.0003	0.00962	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.0003	0.00962	CbGpPWpGaD
Valaciclovir—Haematuria—Doxorubicin—kidney cancer	0.0003	0.000379	CcSEcCtD
Valaciclovir—Abdominal pain—Paclitaxel—kidney cancer	0.000299	0.000379	CcSEcCtD
Valaciclovir—Body temperature increased—Paclitaxel—kidney cancer	0.000299	0.000379	CcSEcCtD
Valaciclovir—Headache—Vincristine—kidney cancer	0.000299	0.000378	CcSEcCtD
Valaciclovir—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000297	0.000376	CcSEcCtD
Valaciclovir—Anorexia—Capecitabine—kidney cancer	0.000296	0.000375	CcSEcCtD
Valaciclovir—Sinusitis—Doxorubicin—kidney cancer	0.000295	0.000373	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ACY1—kidney cancer	0.000293	0.00938	CbGpPWpGaD
Valaciclovir—Vomiting—Gemcitabine—kidney cancer	0.000288	0.000364	CcSEcCtD
Valaciclovir—Rash—Gemcitabine—kidney cancer	0.000285	0.000361	CcSEcCtD
Valaciclovir—Dermatitis—Gemcitabine—kidney cancer	0.000285	0.000361	CcSEcCtD
Valaciclovir—Headache—Gemcitabine—kidney cancer	0.000283	0.000359	CcSEcCtD
Valaciclovir—Nausea—Vincristine—kidney cancer	0.000283	0.000359	CcSEcCtD
Valaciclovir—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000283	0.000359	CcSEcCtD
Valaciclovir—Rhinitis—Doxorubicin—kidney cancer	0.000283	0.000358	CcSEcCtD
Valaciclovir—Hepatitis—Doxorubicin—kidney cancer	0.000282	0.000357	CcSEcCtD
Valaciclovir—Insomnia—Capecitabine—kidney cancer	0.000281	0.000356	CcSEcCtD
Valaciclovir—Pharyngitis—Doxorubicin—kidney cancer	0.00028	0.000354	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000279	0.00895	CbGpPWpGaD
Valaciclovir—Paraesthesia—Capecitabine—kidney cancer	0.000279	0.000353	CcSEcCtD
Valaciclovir—Hypersensitivity—Paclitaxel—kidney cancer	0.000279	0.000353	CcSEcCtD
Valaciclovir—Urinary tract disorder—Doxorubicin—kidney cancer	0.000279	0.000353	CcSEcCtD
Valaciclovir—Oedema peripheral—Doxorubicin—kidney cancer	0.000278	0.000352	CcSEcCtD
Valaciclovir—Dyspnoea—Capecitabine—kidney cancer	0.000277	0.000351	CcSEcCtD
Valaciclovir—Urethral disorder—Doxorubicin—kidney cancer	0.000276	0.00035	CcSEcCtD
Valaciclovir—Dyspepsia—Capecitabine—kidney cancer	0.000274	0.000346	CcSEcCtD
Valaciclovir—Asthenia—Paclitaxel—kidney cancer	0.000272	0.000344	CcSEcCtD
Valaciclovir—Decreased appetite—Capecitabine—kidney cancer	0.00027	0.000342	CcSEcCtD
Valaciclovir—Nausea—Gemcitabine—kidney cancer	0.000269	0.00034	CcSEcCtD
Valaciclovir—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000268	0.00034	CcSEcCtD
Valaciclovir—Fatigue—Capecitabine—kidney cancer	0.000268	0.000339	CcSEcCtD
Valaciclovir—Pruritus—Paclitaxel—kidney cancer	0.000268	0.000339	CcSEcCtD
Valaciclovir—Erythema multiforme—Doxorubicin—kidney cancer	0.000267	0.000338	CcSEcCtD
Valaciclovir—Constipation—Capecitabine—kidney cancer	0.000266	0.000337	CcSEcCtD
Valaciclovir—Pain—Capecitabine—kidney cancer	0.000266	0.000337	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000259	0.00831	CbGpPWpGaD
Valaciclovir—Diarrhoea—Paclitaxel—kidney cancer	0.000259	0.000328	CcSEcCtD
Valaciclovir—Feeling abnormal—Capecitabine—kidney cancer	0.000256	0.000324	CcSEcCtD
Valaciclovir—Immune system disorder—Doxorubicin—kidney cancer	0.000255	0.000322	CcSEcCtD
Valaciclovir—Gastrointestinal pain—Capecitabine—kidney cancer	0.000254	0.000322	CcSEcCtD
Valaciclovir—Mediastinal disorder—Doxorubicin—kidney cancer	0.000254	0.000322	CcSEcCtD
Valaciclovir—Chills—Doxorubicin—kidney cancer	0.000253	0.00032	CcSEcCtD
Valaciclovir—Dizziness—Paclitaxel—kidney cancer	0.000251	0.000317	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00025	0.00799	CbGpPWpGaD
Valaciclovir—Alopecia—Doxorubicin—kidney cancer	0.000249	0.000315	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—PDHB—kidney cancer	0.000249	0.00797	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000247	0.00792	CbGpPWpGaD
Valaciclovir—Urticaria—Capecitabine—kidney cancer	0.000247	0.000313	CcSEcCtD
Valaciclovir—Abdominal pain—Capecitabine—kidney cancer	0.000246	0.000311	CcSEcCtD
Valaciclovir—Body temperature increased—Capecitabine—kidney cancer	0.000246	0.000311	CcSEcCtD
Valaciclovir—Flatulence—Doxorubicin—kidney cancer	0.000242	0.000306	CcSEcCtD
Valaciclovir—Tension—Doxorubicin—kidney cancer	0.000241	0.000305	CcSEcCtD
Valaciclovir—Vomiting—Paclitaxel—kidney cancer	0.000241	0.000305	CcSEcCtD
Valaciclovir—Rash—Paclitaxel—kidney cancer	0.000239	0.000302	CcSEcCtD
Valaciclovir—Dermatitis—Paclitaxel—kidney cancer	0.000239	0.000302	CcSEcCtD
Valaciclovir—Nervousness—Doxorubicin—kidney cancer	0.000238	0.000302	CcSEcCtD
Valaciclovir—Back pain—Doxorubicin—kidney cancer	0.000238	0.000301	CcSEcCtD
Valaciclovir—Headache—Paclitaxel—kidney cancer	0.000237	0.0003	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CCBL1—kidney cancer	0.000234	0.00749	CbGpPWpGaD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000231	0.00739	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000229	0.00735	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Capecitabine—kidney cancer	0.000229	0.00029	CcSEcCtD
Valaciclovir—Anaemia—Doxorubicin—kidney cancer	0.000227	0.000287	CcSEcCtD
Valaciclovir—Agitation—Doxorubicin—kidney cancer	0.000226	0.000286	CcSEcCtD
Valaciclovir—Nausea—Paclitaxel—kidney cancer	0.000225	0.000285	CcSEcCtD
Valaciclovir—Asthenia—Capecitabine—kidney cancer	0.000223	0.000282	CcSEcCtD
Valaciclovir—Pruritus—Capecitabine—kidney cancer	0.00022	0.000278	CcSEcCtD
Valaciclovir—Leukopenia—Doxorubicin—kidney cancer	0.00022	0.000278	CcSEcCtD
Valaciclovir—Cough—Doxorubicin—kidney cancer	0.000214	0.000271	CcSEcCtD
Valaciclovir—Convulsion—Doxorubicin—kidney cancer	0.000213	0.000269	CcSEcCtD
Valaciclovir—Diarrhoea—Capecitabine—kidney cancer	0.000213	0.000269	CcSEcCtD
Valaciclovir—Hypertension—Doxorubicin—kidney cancer	0.000212	0.000268	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000212	0.00678	CbGpPWpGaD
Valaciclovir—Chest pain—Doxorubicin—kidney cancer	0.000209	0.000265	CcSEcCtD
Valaciclovir—Myalgia—Doxorubicin—kidney cancer	0.000209	0.000265	CcSEcCtD
Valaciclovir—Arthralgia—Doxorubicin—kidney cancer	0.000209	0.000265	CcSEcCtD
Valaciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000208	0.000263	CcSEcCtD
Valaciclovir—Dizziness—Capecitabine—kidney cancer	0.000206	0.00026	CcSEcCtD
Valaciclovir—Dry mouth—Doxorubicin—kidney cancer	0.000204	0.000259	CcSEcCtD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000204	0.00654	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GLIPR1—kidney cancer	0.000203	0.0065	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PPAT—kidney cancer	0.000203	0.0065	CbGpPWpGaD
Valaciclovir—Confusional state—Doxorubicin—kidney cancer	0.000202	0.000256	CcSEcCtD
Valaciclovir—Anaphylactic shock—Doxorubicin—kidney cancer	0.0002	0.000254	CcSEcCtD
Valaciclovir—Oedema—Doxorubicin—kidney cancer	0.0002	0.000254	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.0002	0.00642	CbGpPWpGaD
Valaciclovir—Infection—Doxorubicin—kidney cancer	0.000199	0.000252	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000198	0.00635	CbGpPWpGaD
Valaciclovir—Vomiting—Capecitabine—kidney cancer	0.000198	0.00025	CcSEcCtD
Valaciclovir—Nervous system disorder—Doxorubicin—kidney cancer	0.000197	0.000249	CcSEcCtD
Valaciclovir—Thrombocytopenia—Doxorubicin—kidney cancer	0.000196	0.000248	CcSEcCtD
Valaciclovir—Rash—Capecitabine—kidney cancer	0.000196	0.000248	CcSEcCtD
Valaciclovir—Dermatitis—Capecitabine—kidney cancer	0.000196	0.000248	CcSEcCtD
Valaciclovir—Tachycardia—Doxorubicin—kidney cancer	0.000196	0.000248	CcSEcCtD
Valaciclovir—Headache—Capecitabine—kidney cancer	0.000195	0.000247	CcSEcCtD
Valaciclovir—Skin disorder—Doxorubicin—kidney cancer	0.000195	0.000246	CcSEcCtD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000193	0.00617	CbGpPWpGaD
Valaciclovir—Anorexia—Doxorubicin—kidney cancer	0.000191	0.000242	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—FH—kidney cancer	0.000189	0.00604	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—APRT—kidney cancer	0.000189	0.00604	CbGpPWpGaD
Valaciclovir—Nausea—Capecitabine—kidney cancer	0.000185	0.000234	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000184	0.0059	CbGpPWpGaD
Valaciclovir—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000183	0.000231	CcSEcCtD
Valaciclovir—Insomnia—Doxorubicin—kidney cancer	0.000181	0.000229	CcSEcCtD
Valaciclovir—Paraesthesia—Doxorubicin—kidney cancer	0.00018	0.000228	CcSEcCtD
Valaciclovir—Dyspnoea—Doxorubicin—kidney cancer	0.000179	0.000226	CcSEcCtD
Valaciclovir—Somnolence—Doxorubicin—kidney cancer	0.000178	0.000226	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—GPC3—kidney cancer	0.000177	0.00568	CbGpPWpGaD
Valaciclovir—Dyspepsia—Doxorubicin—kidney cancer	0.000176	0.000223	CcSEcCtD
Valaciclovir—Decreased appetite—Doxorubicin—kidney cancer	0.000174	0.000221	CcSEcCtD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000173	0.00555	CbGpPWpGaD
Valaciclovir—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000173	0.000219	CcSEcCtD
Valaciclovir—Fatigue—Doxorubicin—kidney cancer	0.000173	0.000219	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—CA2—kidney cancer	0.000173	0.00553	CbGpPWpGaD
Valaciclovir—Constipation—Doxorubicin—kidney cancer	0.000171	0.000217	CcSEcCtD
Valaciclovir—Pain—Doxorubicin—kidney cancer	0.000171	0.000217	CcSEcCtD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00017	0.00546	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ALAD—kidney cancer	0.000168	0.00538	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000167	0.00536	CbGpPWpGaD
Valaciclovir—Feeling abnormal—Doxorubicin—kidney cancer	0.000165	0.000209	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ST3GAL2—kidney cancer	0.000164	0.00526	CbGpPWpGaD
Valaciclovir—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000164	0.000207	CcSEcCtD
Valaciclovir—SLC10A2—Metabolism—ALDH1A1—kidney cancer	0.00016	0.00514	CbGpPWpGaD
Valaciclovir—Urticaria—Doxorubicin—kidney cancer	0.000159	0.000202	CcSEcCtD
Valaciclovir—Body temperature increased—Doxorubicin—kidney cancer	0.000158	0.000201	CcSEcCtD
Valaciclovir—Abdominal pain—Doxorubicin—kidney cancer	0.000158	0.000201	CcSEcCtD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000158	0.00507	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PGK1—kidney cancer	0.000154	0.00492	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC5A3—kidney cancer	0.000154	0.00492	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000153	0.0049	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—LDHB—kidney cancer	0.000151	0.00483	CbGpPWpGaD
Valaciclovir—Hypersensitivity—Doxorubicin—kidney cancer	0.000148	0.000187	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000147	0.00472	CbGpPWpGaD
Valaciclovir—Asthenia—Doxorubicin—kidney cancer	0.000144	0.000182	CcSEcCtD
Valaciclovir—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000142	0.00456	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000142	0.00455	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000142	0.00455	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000142	0.00455	CbGpPWpGaD
Valaciclovir—Pruritus—Doxorubicin—kidney cancer	0.000142	0.000179	CcSEcCtD
Valaciclovir—Diarrhoea—Doxorubicin—kidney cancer	0.000137	0.000174	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000137	0.00438	CbGpPWpGaD
Valaciclovir—Dizziness—Doxorubicin—kidney cancer	0.000133	0.000168	CcSEcCtD
Valaciclovir—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000132	0.00423	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000132	0.00423	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000132	0.00422	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000132	0.00422	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000132	0.00422	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CA9—kidney cancer	0.000131	0.00419	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000128	0.00409	CbGpPWpGaD
Valaciclovir—Vomiting—Doxorubicin—kidney cancer	0.000127	0.000161	CcSEcCtD
Valaciclovir—Rash—Doxorubicin—kidney cancer	0.000126	0.00016	CcSEcCtD
Valaciclovir—Dermatitis—Doxorubicin—kidney cancer	0.000126	0.00016	CcSEcCtD
Valaciclovir—Headache—Doxorubicin—kidney cancer	0.000126	0.000159	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000122	0.0039	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000121	0.00387	CbGpPWpGaD
Valaciclovir—Nausea—Doxorubicin—kidney cancer	0.000119	0.000151	CcSEcCtD
Valaciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000118	0.00376	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000117	0.00375	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000117	0.00375	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000117	0.00375	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CRABP1—kidney cancer	0.000111	0.00356	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ITPR2—kidney cancer	0.000103	0.00331	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000102	0.00325	CbGpPWpGaD
Valaciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	9.81e-05	0.00314	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	9.78e-05	0.00313	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	9.78e-05	0.00313	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	9.78e-05	0.00313	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.53e-05	0.00305	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ACHE—kidney cancer	9.43e-05	0.00302	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTT1—kidney cancer	9.43e-05	0.00302	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SCARB1—kidney cancer	8.92e-05	0.00286	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS1—kidney cancer	8.83e-05	0.00283	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PSMD7—kidney cancer	8.66e-05	0.00277	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—BCHE—kidney cancer	8.21e-05	0.00263	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC5A5—kidney cancer	8.11e-05	0.0026	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—SLC2A1—kidney cancer	7.83e-05	0.00251	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.6e-05	0.00243	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.49e-05	0.0024	CbGpPWpGaD
Valaciclovir—SLC10A2—Transmembrane transport of small molecules—RAF1—kidney cancer	7.47e-05	0.00239	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.23e-05	0.00232	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.95e-05	0.00223	CbGpPWpGaD
Valaciclovir—SLC6A14—Transmembrane transport of small molecules—RAF1—kidney cancer	6.83e-05	0.00219	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.71e-05	0.00215	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.63e-05	0.00212	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTP1—kidney cancer	6.53e-05	0.00209	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—ABCB1—kidney cancer	6.18e-05	0.00198	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.18e-05	0.00198	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—GSTM1—kidney cancer	6e-05	0.00192	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.97e-05	0.00191	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.71e-05	0.00183	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—CYP1A1—kidney cancer	5.69e-05	0.00182	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.3e-05	0.0017	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.16e-05	0.00165	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.98e-05	0.0016	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.71e-05	0.00151	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.68e-05	0.0015	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—POMC—kidney cancer	4.24e-05	0.00136	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.93e-05	0.00126	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTGS2—kidney cancer	3.38e-05	0.00108	CbGpPWpGaD
Valaciclovir—SLC15A2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.23e-05	0.00103	CbGpPWpGaD
Valaciclovir—SLC15A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3e-05	0.00096	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PTEN—kidney cancer	2.95e-05	0.000945	CbGpPWpGaD
Valaciclovir—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	2.67e-05	0.000854	CbGpPWpGaD
Valaciclovir—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	2.23e-05	0.000713	CbGpPWpGaD
Valaciclovir—SLC10A2—Metabolism—PIK3CA—kidney cancer	2.08e-05	0.000667	CbGpPWpGaD
